Reduction of Connexin36 Content by ICER-1 Contributes to Insulin-Secreting Cells Apoptosis Induced by Oxidized LDL Particles

作者: Jacques-Antoine Haefliger , David Martin , Dimitri Favre , Yannick Petremand , Lucia Mazzolai

DOI: 10.1371/JOURNAL.PONE.0055198

关键词:

摘要: Connexin36 (Cx36), a trans-membrane protein that forms gap junctions between insulin-secreting beta-cells in the Langerhans islets, contributes to proper control of insulin secretion and beta-cell survival. Hypercholesterolemia pro-atherogenic low density lipoproteins (LDL) contribute dysfunction apoptosis context Type 2 diabetes. We investigated impact LDL-cholesterol on Cx36 levels beta-cells. As compared WT mice, content was reduced islets from hypercholesterolemic ApoE-/- mice. Prolonged exposure human native (nLDL) or oxidized LDL (oxLDL) particles decreased expression secreting cell-lines isolated rodent islets. down-regulation associated with overexpression inducible cAMP early repressor (ICER-1) selective disruption ICER-1 prevented effects oxLDL expression. Oil red O staining Plin1 suggested were less stored as neutral lipid droplets than nLDL INS-1E cells. The beta-oxidation inhibitor etomoxir enhanced oxLDL-induced whereas ceramide synthesis myriocin partially protected cells, suggesting toxicity due impaired metabolism lipids. expressions closely correlated toxicity. knock-down cells knock-out primary sensitized apoptosis. In contrast, against These data demonstrate reduction by is mediated

参考文章(51)
V S Kashyap, S Santamarina-Fojo, D R Brown, C L Parrott, D Applebaum-Bowden, S Meyn, G Talley, B Paigen, N Maeda, H B Brewer, Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. Journal of Clinical Investigation. ,vol. 96, pp. 1612- 1620 ,(1995) , 10.1172/JCI118200
Wissal El-Assaad, Jean Buteau, Marie-Line Peyot, Christopher Nolan, Raphael Roduit, Serge Hardy, Erik Joly, Ghassan Dbaibo, Lawrence Rosenberg, Marc Prentki, Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death Endocrinology. ,vol. 144, pp. 4154- 4163 ,(2003) , 10.1210/EN.2003-0410
Kaspar Berneis, Christina Jeanneret, Jürgen Muser, Barbara Felix, André R. Miserez, Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes Metabolism-clinical and Experimental. ,vol. 54, pp. 227- 234 ,(2005) , 10.1016/J.METABOL.2004.08.017
Roland Stocker, John F. Keaney, Role of Oxidative Modifications in Atherosclerosis Physiological Reviews. ,vol. 84, pp. 1381- 1478 ,(2004) , 10.1152/PHYSREV.00047.2003
Marja-Riitta Taskinen, LDL-cholesterol, HDL-cholesterol or triglycerides—which is the culprit? Diabetes Research and Clinical Practice. ,vol. 61, ,(2003) , 10.1016/S0168-8227(03)00126-8
A. Abderrahmani, G. Niederhauser, D. Favre, S. Abdelli, M. Ferdaoussi, J. Y. Yang, R. Regazzi, C. Widmann, G. Waeber, Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia. ,vol. 50, pp. 1304- 1314 ,(2007) , 10.1007/S00125-007-0642-Z
D. Favre, G. Niederhauser, D. Fahmi, V. Plaisance, S. Brajkovic, N. Beeler, F. Allagnat, J. A. Haefliger, R. Regazzi, G. Waeber, A. Abderrahmani, Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets. Diabetologia. ,vol. 54, pp. 2337- 2346 ,(2011) , 10.1007/S00125-011-2165-X
T C Nogueira, D Delaroche, N Welsh, L Marselli, P Marchetti, J A Haefliger, D L Eizirik, A K Cardozo, F Allagnat, M Fukaya, C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. Cell Death & Differentiation. ,vol. 19, pp. 1836- 1846 ,(2012) , 10.1038/CDD.2012.67
Jannick Pétremand, Amar Abderrahmani, Christian Widmann, Genetics and molecular biology: HDLs and their multiple ways to protect cells. Current Opinion in Lipidology. ,vol. 19, pp. 95- 97 ,(2008) , 10.1097/MOL.0B013E3282F41982
Kevin Jon Williams, Edward A Fisher, Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 8, pp. 139- 146 ,(2005) , 10.1097/00075197-200503000-00006